Hematology, Transfusion and Cell Therapy

Elsevier

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Hematology, Transfusion and Cell Therapy is an open-access journal published by Elsevier in Spain, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 30 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2531-1379 · 2531-1387
Country
Spain
Languages
english
Access
Open access
Articles in DOAJ
7445
Declared review time
30 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2018-05-01
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
30 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

7445

Most recent article

last month

Average review time (journal-declared via DOAJ)

30weeks

Works in OpenAlex

11020

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

30

i10-index

177

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2026-04-27
Added to DOAJ
2018-05-01
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
8%
ORCID iDs in current deposits
8%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity4
Continues
1516-8484, 1806-0870
Source type
journal
NLM unique ID (PubMed)
101725732
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

LCC codes

RC633-647.5

Subject areas

  • Blood transfusion and management
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Lymphoma Diagnosis and Treatment
  • Blood donation and transfusion practices
  • Blood groups and transfusion
  • Acute Myeloid Leukemia Research
  • Hemoglobinopathies and Related Disorders
Show all subjects (75)
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Blood donation and transfusion practices
  • Blood donation and transfusion practices
  • Hematological disorders and diagnostics
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • Platelet Disorders and Treatments
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Healthcare during COVID-19 Pandemic
  • Healthcare during COVID-19 Pandemic
  • Viral-associated cancers and disorders
  • Multiple Myeloma Research and Treatments
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Blood groups and transfusion
  • Retinoids in leukemia and cellular processes
  • Blood groups and transfusion
  • Academic Research in Diverse Fields
  • Academic Research in Diverse Fields
  • Clinical Laboratory Practices and Quality Control
  • Hemophilia Treatment and Research
  • Science and Education Research
  • Science and Education Research
  • Blood transfusion and management
  • Blood transfusion and management
  • Chronic Myeloid Leukemia Treatments
  • Maternal and Neonatal Healthcare
  • Maternal and Neonatal Healthcare
  • Palliative and Oncologic Care
  • Palliative and Oncologic Care
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Women's cancer prevention and management
  • Women's cancer prevention and management
  • T-cell and Retrovirus Studies
  • T-cell and Retrovirus Studies
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Iron Metabolism and Disorders
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Blood Coagulation and Thrombosis Mechanisms
  • Complement system in diseases
  • Public Health in Brazil
  • Public Health in Brazil
  • Neutropenia and Cancer Infections
  • Healthcare Regulation
  • Healthcare Regulation
  • Hemophilia Treatment and Research
  • CNS Lymphoma Diagnosis and Treatment
  • Hemophilia Treatment and Research
  • Rural and Ethnic Education
  • Rural and Ethnic Education
  • Cutaneous lymphoproliferative disorders research
  • Cutaneous lymphoproliferative disorders research
  • Organ Donation and Transplantation

Keywords (DOAJ)

  • case reports
  • hematology
  • transfusion
  • hemotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: